The telehealth company made a big acquisition and bumped up its Q4 guidance.
News & Analysis: Teladoc Health
There's no time like the present to buy this high-flying healthcare stock.
These companies are growing rapidly, and their momentum should continue regardless of what happens on Election Day.
Keep your eye on this pair of emerging technologies.
The company is expanding its reach in the fragmented healthcare industry.
Momentum continued to build for the telemedicine leader.
At a health conference on Monday, the telemedicine provider gave additional details about the acquisition, as well as preliminary financial results for its fourth quarter.
The company is making a bold move into the hospital setting.
The acquisition increases the clinical uses of Teladoc's telemedicine platform.
Positive industry trends should benefit these companies.